✦ LIBER ✦

A double-blind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis

✍ Scribed by S. Devadatta; N.K. Menon; O. Nazareth; S. Radhakrishna; C.V. Ramakrishnan; P.R. Somasundaram; S.P. Usha; S. Velu

Book ID: 113207978
Publisher: Elsevier Science
Year: 1970
Tongue: English
Weight: 609 KB
Volume: 51
Category: Article
ISSN: 0041-3879
DOI: 10.1016/0041-3879(70)90018-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a phase I study to determine

Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck

✍ Andrew J. Sykes; Nick J. Slevin; Robert H. MacDougall; Janet A.D. Ironside; Kath 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 86 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

A phase I, double-blind, randomized, pla

A phase I, double-blind, randomized, placebo-controlled study to investigate the safety tolerability and pharmacokinetic profile of S-3304, a matrix metalloproteinase inhibitor, when given in multiple doses with high doses for 4 weeks to healthy volunteers

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Effect of the Adenosine A1 Receptor Anta

Effect of the Adenosine A1 Receptor Antagonist, KW-3902, on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure Refractory to Maximum Doses of Conventional Diuretics: A Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study

✍ Michael M. Givertz; Michael Tansey; Leeanne L. Pearson; Tara K. Fields; Howard C 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 189 KB

A placebo-controlled, double-blind, dose

A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock

✍ Peter E Morris; Brian Zeno; Andrew C Bernard; Xiangning Huang; Shampa Das; Timi 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 300 KB

A multicentre, double-blind, randomized,

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy

✍ T Betts; T Waegemans; P Crawford 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB